Publications by authors named "Pj P"
Article Synopsis
- Lichen sclerosus et atrophicus (LSEA) is a chronic skin condition affecting both genders, predominantly seen in postmenopausal women and can present in genital or extragenital areas.
- The study analyzed 20 LSEA patients from a South Indian teaching hospital, finding most were female, with a significant portion being postmenopausal and many experiencing associated health issues like joint pain and hypertension.
- The research highlights the need for careful diagnosis to distinguish LSEA from other skin disorders and suggests further investigation into its links with autoimmune diseases.
Lidocaine Induced Laryngeal Angioedema in Sweet Syndrome: Is it incidental or anticipated?
Indian J Otolaryngol Head Neck Surg
June 2023
Unlabelled: Sweet's Syndrome is a rare inflammatory disease in which there is neutrophilic infiltration of the cutaneous tissue with or without vasculitis. Rarely, the extra-cutaneous tissue is affected. In the ENT Clinic, Sweet Syndrome can have variable manifestations due to the possible co-existing vasculitis and autoimmune diseases.
View Article and Find Full Text PDFObjective: The study was conducted to compare the pre-electroconvulsive therapy (ECT) and post-ECT status of the executive functions of patients and report any deficits found at long-term follow-up. The secondary objective of the study was to compare the performance at executive function tests after ECT with patient characteristics and ECT parameters.
Methodology: In a prospective longitudinal observational study, 50 patients in the age group of 18 to 65 years who were receiving modified bifrontotemporal ECT for the first time and admitted in psychiatry ward of a tertiary care hospital from July 2015 to June 2016 were assessed for executive functions using a neuropsychological battery consisting of digit span forward, digit span backward, spatial span forward, spatial span backward, phonemic verbal fluency test, semantic verbal fluency test, Stroop test, and Wisconsin Card Sorting Test, a day before ECT and then followed up at 3 and 6 months.